Cargando…
Clonal dominance of CD133(+) subset population as risk factor in tumor progression and disease recurrence of human cutaneous melanoma
Chemotherapeutic refractoriness of advanced cutaneous melanoma may be linked with melanoma-initiating cells, also known as melanoma stem cells. This study aimed to determine relative risk of clonal dominance of the CD133(+) phenotype in tissues from melanoma patients with different clinical outcomes...
Autores principales: | SHARMA, BHUVNESH K., MANGLIK, V., O’CONNELL, MICHAEL, WEERARATNA, ASHANI, McCARRON, EDWARD C., BROUSSARD, JENNIFER N., DiVITO, KYLE A., SIMBULAN-ROSENTHAL, CYNTHIA M., ROSENTHAL, DEAN S., ZAPAS, JOHN L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583984/ https://www.ncbi.nlm.nih.gov/pubmed/22922842 http://dx.doi.org/10.3892/ijo.2012.1590 |
Ejemplares similares
-
CD133 Is Associated with Increased Melanoma Cell Survival after Multikinase Inhibition
por: Simbulan-Rosenthal, Cynthia M., et al.
Publicado: (2019) -
Id3 induces an Elk-1–caspase-8-dependent apoptotic pathway in squamous carcinoma cells
por: Chen, You-Shin, et al.
Publicado: (2015) -
Employing CRISPR-Cas9 to Generate CD133 Synthetic Lethal Melanoma Stem Cells
por: Simbulan-Rosenthal, Cynthia M., et al.
Publicado: (2022) -
CRISPR-Cas9 Knockdown and Induced Expression of CD133 Reveal Essential Roles in Melanoma Invasion and Metastasis
por: Simbulan-Rosenthal, Cynthia M., et al.
Publicado: (2019) -
ROCK inhibitor reduces Myc-induced apoptosis and mediates immortalization of human keratinocytes
por: Dakic, Aleksandra, et al.
Publicado: (2016)